William Antonios-McCrea
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Synthesis and Catalytic Reactions, Angiogenesis and VEGF in Cancer, HER2/EGFR in Cancer Research, Chemical Synthesis and Analysis
Most-Cited Works
- → Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors(2008)135 cited
- → Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma(2015)54 cited
- → Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990(2014)27 cited
- → LHMDS mediated tandem acylation–cyclization of 2-aminobenzenecarbonitriles with 2-benzymidazol-2-yl acetates: a short and efficient route to the synthesis of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones(2005)7 cited
- → LHMDS‐Mediated Tandem Acylation—Cyclization of 2‐Aminobenzenecarbonitriles with 2‐Benzimidazol‐2‐yl Acetates: A Short and Efficient Route to the Synthesis of 4‐Amino‐3‐benzimidazol‐2‐ylhydroquinolin‐2‐ones.(2006)